 |
|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
- Therapeutics-Clinical (Late) - - - ,
- - -
Accentia Biopharmaceuticals - Tampa,
FL ; Tampa, FL - acquisition of late stage pharmaceuticals and improvement through new delivery technologies
Acorda Therapeutics - Hawthorne,
NY - spinal cord injury-based therapeutics
Acusphere - Watertown,
MA - drug delivery using porus microparticles
Adolor - Exton,
PA - pain relief therapeutics
Adventrx Pharmaceuticals - San Diego,
CA - pharmaceutical research through licensing agreements
Alfacell - Bloomfield,
NJ - RNase therapeutics
Alizyme - Cambridge,
UK - drug development, focusing on obesity and diabetes
Allos Therapeutics - Westminster,
CO - cancer therapeutics
Amarin - London,
UK; Mill Valley, CA ; Sweden - therapeutics for neurology and pain management
AnorMED - Vancouver,
British Columbia UK - small molecule therapeutics
Antigenics - New York,
NY ; Lexington, MA - therapeutics for the treatment of cancer, infectious diseases and autoimmune disorders
Aphios - Woburn,
MA - infectious disease and cancer therapeutics
Aphton - Miami,
FL - cancer immunotherapeutics
AtheroGenics - Alpheretta,
GA - development small molecule therapeutics for chronic inflammatory diseases
Avant Immunotherapeutics - Needham,
MA - develops immunotherapeutics
Axonyx - New York,
NY - acquisition and development of memory-related therapeutics
BCY LifeSciences - Toronto,
Ontario Canada - late stage pharmaceutical development company
Biomira - Bellevue,
WA ; Edmonton, Alberta, Canada ; Tucson, AZ - immunotherapy and cancer therapeutics (cancer vaccines)
BioNumerik - San Antonio,
TX - cancer therapeutics
BioSante Pharmaceuticals - Lincolnshire,
IL - hormone therapeutics
BioSpecifics Technologies - Lynbrook,
NY - wound healing and tissue remodeling therapeutics
Biosyn - Huntingdon Valley,
PA - infectious disease and reproductive health therapeutics
Biothera - Eagan,
MN - complex carbohydrate biopolymers therapeutics and products
CancerVax Corp. - Carlsbad,
CA ; Marina Del Ray, CA - therapeutic cancer vaccines and angiogenesis-controlling antibodies
Cellegy Pharmaceuticals - South San Francisco,
CA - therapeutics targeting gastroenterology conditions and sexual dysfunction using topical formulations and nitric oxide donor technologies
CeNeS Pharmaceuticals - Cambridge,
UK - drug development in the areas of pain, anaesthesia and neurology.
Cerus - Concord,
CA - therapeutics based on the inhibition of nucleic acid replication
Chrysalis BioTechnology - Galveston,
TX - tissue repair therapeutics
Corgentech - South San Francisco,
CA - therapeutics based on transcription factor decoys
Cubist Pharmaceuticals - Lexington,
MA ; Slough, Berkshire, UK - antimicrobial drug development
Curacyte - Munich,
Germany; Chapel Hill, NC. - biopharmaceutical company
CV Therapeutics - Palo Alto,
CA - small molecule therapeutics for cardiovascular disease
Cypress Bioscience - San Diego,
CA - therapeutics for fibromyalgia syndrome
Debiopharm - Lausanne,
Switzerland - development of in-licensed therapeutics
Dendreon - Seattle,
WA - monoclonal antibody therapeutics for cancer treatments
Discovery Labs - Doylestown,
PA - respiratory therapeutics
DOR BioPharma - Ewing,
NJ - oral and mucosal drug delivery
Dragon Pharmaceuticals - Vancouver,
B.C. Canada - genetically engineered human proteins for therapeutic use
Dynavax - Berkeley,
CA - development of therapeutics based on "immunostimulatory sequences"
DynPort Vaccine - Frederick,
MD - vaccine therapeutics for biodefense purposes
EMD Pharmaceuticals - Durham,
NC - cancer and diabetes therapeutics
Encysive Pharmaceuticals - Houston,
TX - small molecule drug development for cardiovascular and inflammatory dieseases
Enhance Biotech - New York,
NY - therapeutics aimed at the lifestyle market (in-licenses products at the clinical trial stage)
ESP Pharma - Edison,
NJ - acquisition and development of commercially available therapeutics and late-stage development specialty drugs
Favrille - San Diego,
CA - develops patient-specific immunotherapeutics for lymphoma and diseases of the immune system
Genelabs Technologies - Redwood City,
CA - SLE (Lupus) therapeutics
Genitope - Fremont,
CA - cancer immunotherapeutics
H3 Pharma - Montreal,
Quebec Canada - development of in-licensed therapeutics through clinical trials
Halozyme Therapeutics - San Diego,
CA - recombinant human enzyme therapeutics
IDM Pharma - Irvine,
CA - immunotherapeutics for the treatment of cancer
Igeneon - Vienna,
Austria - cancer immunotherapeutics
ImClone Systems - New York,
NY - monoclonal antibody cancer therapeutics
Indevus Pharmaceuticals - Lexington,
MA - acquisition and development of late stage clinical compounds
Inex Pharmaceuticals - Burnaby,
British Columbia Canada - cancer therapeutics and drug delivery systems
InSite Vision - Alameda,
CA - ophthalmic diagnositcs and drug delivery
Inspire Pharmaceuticals - Durham,
NC - therapeutics for the trestment of mucosal deficiency diseases
IntraBiotics Pharmaceuticals - Mountain View,
CA - antimicrobial and oncology therapeutics
Introgen Therapeutics - Austin,
TX ; Houston, TX - gene-based therapeutics
Ista Pharmaceuticals - Irvine,
CA - Hyaluronidase-based therapeutics for eye diseases
Maxim Pharmaceuticals - San Diego,
CA - histamine-related drug therapies
MGI Pharma - Bloomington,
MN - oncology therapeutic development and manufacturing
NeoRx - Seattle,
WA - targeted delivery of cancer therapeutics
Neurocrine Biosciences - San Diego,
CA - discovery and development of neurological disease therapeutics
Newron Pharmaceuticals - Bresso (Milan),
Italy - CNS and pain pharmaceuticals
NitroMed - Bedford,
MA - nitric oxide-based therapeutics
NPS Pharmaceuticals - Salt Lake City,
UT - small molecule and recombinant protein therapeutics
Onyx Pharmaceuticals - Emeryville,
CA - human disease therapuetics
Oscient Pharmaceuticals - Waltham,
MA - genomics-based pharmaceuticals and genomic services
Ovation Pharmaceuticals - Deerfield,
IL - acquisition of branded and late stage clinical therapeutics
Pain Therapeutics - South San Francisco,
CA - painkiller development
Peninsula Pharmaceuticals - Alameda,
CA - anti-infective therapeutics
Pharmacyclics - Sunnyvale,
CA Sunnyvale, CA - small molecule (texaphyrins)-based pharmaceuticals
Pharmaxis - Sydney,
Australia - therapeutics for the treatment of chronic respiratory and autoimmune diseases
Pharmos - Iselin,
NJ ; Rehovot, Israel - CNS therapeutics
Pozen - Chapel Hill,
NC - migraine therapeutics, focusing on drug development
Regeneron Pharmaceuticals - Tarrytown,
NY ; Rensselaer, NY - therapeutics for treatment of obesity, rheumatoid arthritis, and cancer
Renovis - South San Francisco,
CA - neurological therapeutics
Santarus - San Diego,
CA - specialty pharmaceuticals company focusing on acquiring drugs for the treatment of gastrointestinal diseases and disorders.
SciClone Pharmaceuticals - San Mateo,
CA - infectious disease and cancer therapeutics
Sequella - Rockville,
MD - tuberculosis research and therapeutics (through in-licensing)
Sinclair Pharmaceuticals - Godalming,
Surrey UK - late stage pharmaceutical development and marketing
Sosei - Tokyo,
Japan - therapeutics development primarily through in-licensing
Spectrum Pharmaceuticals - Irvine,
CA - in-licensing, clinical development and commercialization of oncology drugs
SuperGen - Dublin,
CA - oncology therapeutics (generally acquired in late stage development)
Tercica - South San Francisco,
CA - endocrine therapeutics
Tolerx - Cambridge,
MA - immune system therapeutics
Trimeris - Durham,
NC - HIV therapeutic development
Unigene Laboratories - Fairfield,
NJ - oral and nasal delivery of large-market peptide drugs
Vasogen - Mississauga,
Ontario Canada - immune modulation therapies for the treatment of cardiovascular disease
VaxGen - Brisbane,
CA - vaccine therapeutics
Verus Pharmaceuticals - San Diego,
CA - pediatric therapeutics
Vical - San Diego,
CA - "naked DNA" gene delivery for disease treatment
Vicuron Pharmaceuticals - Fremont,
CA - antibiotic and antifungal therapeutics
Vion Pharmaceuticals - New Haven,
CT - cancer therapeutics
ViRexx Medical - Edmonton,
Alberta Canada - cancer therapeutics
Wilex - Munich,
Germany - small molecule and antibody cancer therapeutics
YM BioSciences - Mississauga,
Ontario Canada - clinical development of cancer therapeutics
|
|
